Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Clinical trial NCT00717236 · COMPLETED

Trial details

NCT number: NCT00717236
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2008-07-01
Primary completion: 2010-03-01
Enrollment: 1648

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.